Marstacimab
GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

GSK acquires Nuvalent for US$ 10.6 bn to expand its oncology portfolio; Roche inks up to US$ 2.3 bn deal with Nurix

This week, Phispers brings you several developments in the field of oncology. One, GSK acquired a Boston-based clinical-stage b...

Impressions : 753

CBER director forced out in FDA gutting; Sanofi, Alnylam’s RNAi therapy Qfitlia wins US approval for hemophilia A, B

CBER director forced out in FDA gutting; Sanofi, Alnylam’s RNAi therapy Qfitlia wins US approval for hemophilia A, B

The pharma industry saw its most tumultuous week in the recent past with the US Food and Drug Administration (FDA) facing an un...

Impressions : 1153

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

Lilly to invest US$ 27 bn in US as Trump threatens big pharma with tariffs; FDA scrambles to rehire after mass layoffs

In the US, President Donald Trump has been putting pressure on Big Pharma to reshore or face tariffs. Eli Lilly has been the ...

Impressions : 1276